Cappuzzo F, Ricciuti B, Delmonte A, Bonanno L, et al. MAPK pathway activating alteration and immunotherapy efficacy in squamous cell lung carcinoma: results from the randomized, prospective SQUINT trial. Clin Cancer Res 2025 Jan 21. doi: 10.1158/1078-0432.CCR-24-2077.
PMID: 39836372